FindTrial
Sign In

A Study Comparing the Efficacy of three different doses of Magnesium Sulphate as Adjuvant to Ropivacaine for Supraclavicular Brachial plexus block

Efficacy of the three different doses of Magnesium Sulphate as an adjuvant in Supraclavicular Brachial plexus block for upper limb surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046410
Enrollment
72
Registered
2022-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Motor and Sensory blockade following Supraclavicular brachial plexus block: Efficacy of three differet doses of Magnesium Sulphate as an adjuvant to 0.5% Ropivacaine. Control Interventi

Sponsors

Sri Venkateshwara Medical College Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1,Patient undergoing elective upper limb surgeries, 2,Age 18-60 years 3,Body weight 45-75kg 4,ASA I and II

Exclusion criteria

Exclusion criteria: 1,Patient Refusal 2,Age 65 years. 3,pregnant Women 4,ASA III and above 5,infection at the site of block 6,H/O allergy to local anesthetic drugs.

Design outcomes

Primary

MeasureTime frame
Onset of sensory and motor blockade following administration of supraclavicular block.Timepoint: The onset and degree of sensory and motor block will be observed and recorded for the first 30 mins in every 5 minute interval.—

Secondary

MeasureTime frame
Compare the hemodynamic changes, Nausea, Vomiting, Pruritis.Timepoint: Outcome is assessed immediately after surgery and up to 24 hours after surgery.—

Countries

India

Contacts

Public ContactYamni S V

Sri Venkateswara Medical college.

dr.jayashridevi@gmail.com8754689690

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026